Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML

Annalisa Lonetti, Valentina Indio, Maria Antonella Laginestra, Giuseppe Tarantino, Francesca Chiarini, Annalisa Astolfi, Salvatore N Bertuccio, Alberto M Martelli, Franco Locatelli, Andrea Pession, Riccardo Masetti

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of MLL-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML'. Together they form a unique fingerprint.

Medicine & Life Sciences